Brief: Biogaia's Probiotic Protectis Increases Sars-Cov-2 Antibody Response

Biogaia AB

05/07/2023 15:33

July 5 (Reuters) - Biogaia AB  BIOGb.ST :
    * BIOGAIA'S PROBIOTIC PROTECTIS INCREASES SARS-COV-2
ANTIBODY
RESPONSE IN ADULTS
    * STUDY WITH BIOGAIA'S PROBIOTIC PROTECTIS WAS SHOWN TO
INCREASE
SARS-COV-2 ANTIBODY TITRES IN HEALTHY VOLUNTEERS WHEN 28 DAYS OR
MORE HAD ELAPSED FROM VACCINATION
    * STUDY INCLUDED 159 HEALTHY ADULTS WITHOUT PRIOR SARS-COV-2
INFECTION OR COVID-19 VACCINATION
    * VACCINATED INDIVIDUALS WHO CONSUMED BIOGAIA PROTECTIS
SHOWED
SIGNIFICANTLY INCREASED IGA ANTIBODY LEVELS WHEN 28 DAYS OR MORE
HAD ELAPSED FROM VACCINATION

Source text for Eikon:  ID:nWkr4vXdyj 
Further company coverage:  BIOGb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))